| Income Statement |
| Operating Expenses | 29.32M |
|
| Research and Development Expense | 20.71M |
| Selling, General and Administrative Expense | 8.62M |
| Operating Income | -29.32M |
| Income Tax Expense | -81.00K |
| Net Income | -26.30M |
| Net Income Common Stock | -26.30M |
| Net Income Common Stock (USD) | -26.30M |
| Consolidated Income | -26.30M |
| Earnings per Basic Share | -0.21 |
| Earnings per Basic Share (USD) | -0.21 |
| Earnings per Diluted Share | -0.21 |
| Earning Before Interest & Taxes (EBIT) | -26.38M |
| Earning Before Interest & Taxes (USD) | -26.38M |
| Weighted Average Shares | 126.80M |
| Weighted Average Shares Diluted | 126.80M |
| Balance Sheet |
| Cash and Equivalents | 205.13M |
| Cash and Equivalents (USD) | 205.13M |
| Current Assets | 210.50M |
| Property, Plant & Equipment Net | 149.00K |
| Total Assets | 213.40M |
| Current Liabilities | 16.32M |
| Total Liabilities | 16.32M |
| Accumulated Retained Earnings (Deficit) | -275.07M |
| Shareholders Equity | 197.09M |
| Shareholders Equity (USD) | 197.09M |
| Assets Non-Current | 2.90M |
| Trade and Non-Trade Payables | 16.32M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 16.00K |
| Net Cash Flow from Financing | 465.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.46M |
| Capital Expenditure | -24.00K |
| Issuance (Purchase) of Equity Shares | 465.00K |
| Net Cash Flow from Investing | -24.00K |
| Net Cash Flow from Operations | -20.90M |
| Share Based Compensation | 4.46M |